enderView.ai
Sign InStart free
ClosedSuppliesEuropeanOnderhandeling zonder bekendmakingGreen

Voluntary transparency regarding the prior supply of DT-IPV vaccine

Rijksinstituut voor Volksgezondheid en Milieu (RIVM) · Onderhandeling zonder bekendmaking · 1 lots · 357989
Type
Supplies
33651600
Estimated value
Not published
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

The National Institute for Public Health and the Environment (RIVM) intends to enter into a supply contract for DT-IPV vaccines for the years 2025 and 2026, with an option to tacitly extend the contract for a maximum of three additional years. The procedure is a negotiation without publication, meaning the tender is not presented publicly. Suppliers must comply with strict quality requirements, EU regulations, and the specific technical specifications of the RIVM. The contract terms include delivery periods, storage requirements, pricing, and a clear clause regarding the extension option. The tender focuses on a reliable, experienced supplier capable of guaranteeing continuous supply and possessing the logistical infrastructure to distribute the vaccines safely. The procedure is aimed at a rapid and efficient selection of a suitable partner, with a focus on quality and reliability.

Supplies · Onderhandeling zonder bekendmaking · European procedure

Sustainability countsEuropean
Contracting authority
Rijksinstituut voor Volksgezondheid en Milieu (RIVM)
Contract type
Supplies
Onderhandeling zonder bekendmaking
Estimated value
Estimate not published
Submission deadline
Ongoing
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
33651600
Location
Netherlands
CharacteristicsCPV 33SuppliesEU tenderGreen / SPPDT-IPVvaccinesupply

01What is being requested

The National Institute for Public Health and the Environment (RIVM) intends to enter into a supply contract for DT-IPV vaccines for the years 2025 and 2026, with an option to tacitly extend the contract for a maximum of three additional years. The procedure is a negotiation without publication, meaning the tender is not presented publicly. Suppliers must comply with strict quality requirements, EU regulations, and the specific technical specifications of the RIVM. The contract terms include delivery periods, storage requirements, pricing, and a clear clause regarding the extension option. The tender focuses on a reliable, experienced supplier capable of guaranteeing continuous supply and possessing the logistical infrastructure to distribute the vaccines safely. The procedure is aimed at a rapid and efficient selection of a suitable partner, with a focus on quality and reliability.

Supply of DT-IPV vaccines Supply contract 2025, 2026 + option to tacitly extend 3 times for 1 year.

33651600Supplies
11—

02Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

03Value in context

Estimate not published

The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.

04Likely competitors

#Likely bidderFitWins
1GlaxoSmithKline B.V.SME776×
2Johnson & Johnson Medical B.V.SME7016×
3Mediost B.V.SME6914×
4Siemens Healthineers Nederland B.V.SME6913×
5CSL Behring GmBHUnknown662×
6King Nederland B.V.SME6510×

05Legal themes that may be relevant here

06Frequently asked questions

What is the duration of the supply contract for the DT-IPV vaccines?
The contract has a duration for the years 2025 and 2026, with an option to tacitly extend the contract a maximum of three times for one year each.

Automatically compiled from the official tender data and documents.

07Estimated value versus the market

p25
€ 317K
median
€ 892K
p75
€ 3,3 mln
deze opdracht

Gegunde waarden in CPV 33 · leveringen n=528